Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
KYMR Kymera Therapeutics Inc posts wider than expected Q4 2025 loss shares gain 182 percent in todays trading CACC Credit Acceptance Corporation Q4 2025 EPS misses estimates shares gain on 72 percent year over year revenue growth Is Microchip MCHPP stock reacting to key levels Eye on Rally 20260418 Is CF Bank CFBK stock gaining upward traction CF Bank posts 135 EPS beat vs analyst estimates ClearSign CLIR Stock Price Action Overview Mini Selloff 20260420 Ferrovial SE FER Stock Is It Undervalued Risk Aversion 20260420 iShares Core MSCI Emerging Markets ETF IEMG Comparative Portfolio Fit and Performance Analysis vs iShares Core MSCI EAFE ETF IEFA Why Your Emergency Savings May Need a Major Overhaul AI Disruption Calls for 18Month Cash Cushion BioAge Labs BIOA Q1 2026 Earnings EPS 052 Beats Estimates Hamilton HG Q1 2026 Beat Revenue NA EPS Exceeds by Significant Cactus WHD Declines 163 Amid Market Weakness 20260515 Texas Roadhouse TXRH Fell 187 Is a Recovery Ahead 20260519 Markets Raise Odds of Fed Rate Hike After Hot Inflation Data PayWhatYouWant Dining One Restaurants Response to Shifting Consumer Habits Trump Seeks Supreme Court Intervention to Delay TikTok Ban Core Inflation Rises to 32 in March as FirstQuarter Growth Slows Oil Surge Challenges Fed Enzo Marescas Expected Appointment as Manchester City Manager Potential Financial Implications for City Football Group WWE Saturday Nights Main Event 2026 Preview Strategic Implications for the Entertainment Giant Asian Markets Track Wall Streets Record Highs Oil Prices Retreat CDP Q1 2026 Earnings Modest EPS Beat Amidst Steady DefenseOriented Portfolio MGPI Q1 2026 Earnings Earnings Surge Past Estimates with 308 Surprise IGC Q1 2026 Earnings Narrowing Losses as Cost Discipline Drives EPS Beat BMBL Q1 2026 Earnings EPS Beat Drives Slight Stock Uptick as User Trends Remain in Focus Silvaco Q1 2026 Earnings EPS Beat Masks Revenue Uncertainty OTLY Q1 2026 Earnings Losses Narrow Sharply as Cost Improvements Exceed Expectations CervoMed Inc CRVO Hovers Near Key Support After Marginal Decline Fulcrum Therapeutics FULC Edges Higher as Biotech Sentiment Stabilizes Global Water Resources GWRS Rallies 7 to 773 Testing Key Resistance Zone Gain Therapeutics GANX Edges Higher as Biotech Sector Shows Mixed Signals MINISO Group MNSO Retreats Toward Support as Selling Pressure Intensifies